GeoVax Labs, Inc. (GOVX) KPIs and segments
Close on Nov 13, 2026Market cap $717.73KP/E –Yield –
KPIs & segments
Operating metrics and segments that drive GeoVax Labs's business
GeoVax Labs's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NIH Grants($M) | 0.17 | 0.03 | 0.08 | 0.11 | 0.25 | 0.23 | 0.30 | 0.65 | 0.23 | 0.21 | 0.18 | ||
NIAID Grant($M) | 0.08 | 0.11 | |||||||||||
Earlier reporting (last reported 2020)2 | |||||||||||||
Rentable area(M sq ft) | 0.0 | 0.0 | 0.0 | 0.0 | |||||||||
1 metric has no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2023-03-23.
See a number that looks wrong?